Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

H Pfeifer; G Cazzaniga; V H J van der Velden; J M Cayuela; B Schäfer; O Spinelli; S Akiki; S Avigad; I Bendit; K Borg; H Cavé; L Elia; S C Reshmi; G Gerrard; S Hayette; M Hermanson; A Juh; T Jurcek; M C Chillón; C Homburg; G Martinelli; V Kairisto; T Lange; T Lion; M C Mueller; F Pane; L Rai; C Damm-Welk; T Sacha; S Schnittger; T Touloumenidou; H Valerhaugen; P Vandenberghe; J Zuna; H Serve; E Herrmann; S Markovic; J J M van Dongen; O G Ottmann

doi:10.1038/s41375-020-0707-2

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Leukemia. 2020 Jul;34(7):1970. doi: 10.1038/s41375-020-0707-2.

Authors

H Pfeifer¹, G Cazzaniga², V H J van der Velden³, J M Cayuela⁴, B Schäfer⁵, O Spinelli⁶, S Akiki⁷, S Avigad⁸, I Bendit⁹, K Borg¹⁰, H Cavé¹¹, L Elia¹², S C Reshmi¹³, G Gerrard¹⁴, S Hayette¹⁵, M Hermanson¹⁶, A Juh¹⁷, T Jurcek¹⁸, M C Chillón¹⁹, C Homburg²⁰, G Martinelli²¹, V Kairisto²², T Lange²³, T Lion²⁴, M C Mueller²⁵, F Pane²⁶, L Rai²⁷, C Damm-Welk²⁸, T Sacha²⁹, S Schnittger³⁰, T Touloumenidou³¹, H Valerhaugen³², P Vandenberghe³³, J Zuna³⁴, H Serve³⁵, E Herrmann³⁶, S Markovic³⁵, J J M van Dongen^#^{3

37}, O G Ottmann^#³⁸

Affiliations

¹ Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany. h.pfeifer@em.uni-frankfurt.de.
² Pediatric Clinic, University of Milan Bicocca, San Gerardo Hospital, Monza, Italy.
³ Department of Immunology, Erasmus MC, University, Medical Center Rotterdam, Rotterdam, The Netherlands.
⁴ Hematology Laboratory and EA3518, University Hospital Saint-Louis, University Paris Diderot, Paris, France.
⁵ Kinderspital Zurich, Onkologie Diagnostik Labor, Zurich, Switzerland.
⁶ Hematology and Bone Marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy.
⁷ Regional Genetics Laboratory, Birmingham Women's NHS Foundation Trust, Birmingham, UK.
⁸ Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
⁹ Division of Hematology and Hemotherapy, Medical School, University of Sao Paulo, Sao Paulo, Brazil.
¹⁰ Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
¹¹ Department of Genetic Biochemistry, Hopital Robert Debre, Paris, France.
¹² Department of Hematology, Laboratory of Molecular Biology, University La Sapienza, Roma, Italy.
¹³ Institute for Genomic Medicine, Nationwide Children's Hospital and the Ohio State University, Columbus, OH, USA.
¹⁴ Imperial Molecular Pathology, Centre for Hematology, Imperial College London, London, UK.
¹⁵ Laboratory of Molecular Biology and UMR5239, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Benite, Lyon, France.
¹⁶ Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
¹⁷ Division of Pediatric Hematology/Oncology, Department of Pediatrics, National University Hospital, Singapore, Singapore.
¹⁸ Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
¹⁹ Department of Hematology, University Hospital of Salamanca (IBSAL) & Cancer Research Centre-IBMCC, (Salamanca University-CSIC), Salamanca, Spain.
²⁰ Department of Experimental Immunhematology/Immuncytology, Sanquin Diagnostics, Amsterdam, The Netherlands.
²¹ Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
²² TYKSLAB, Laboratory of Molecular Genetics, Turku University Hospital, Turku, Finland.
²³ Abteilung fur Hamatologie und internistische Onkologie, Universitat Leipzig, Leipzig, Germany.
²⁴ Childrens Cancer Research Institute, Labdia Labordiagnostik and Medical University, Vienna, Austria.
²⁵ III. Medizinische Klinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany.
²⁶ Azienda Ospedaliera Universitaria Federico II di Napoli Universita, Naples, Italy.
²⁷ Department of Hematology, Royal Free Campus, University College London, London, United Kingdom.
²⁸ Department of Pediatric Hematology and Oncology, University Hospital, Justus Liebig University Giessen, Giessen, Germany.
²⁹ Hematology Department, Jagiellonain University Krakow, Krakow, Poland.
³⁰ MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, Germany.
³¹ Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
³² Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
³³ Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium.
³⁴ CLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and UH Motol, Prague, Czech Republic.
³⁵ Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany.
³⁶ Institut fur Biostatistik und Mathematische Modellierung, Goethe Universitat, Frankfurt, Germany.
³⁷ Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands.
³⁸ School of Medicine, Division of Cancer and Hematology, Cardiff University, Cardiff, UK.

^# Contributed equally.

PMID: 31937894
DOI: 10.1038/s41375-020-0707-2

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum